Evidence map›Paper›PMID 25850010›Full record

Trial reportPloS one2015

Thinprep plus Papanicolaou stain method is more sensitive than cytospin-coupled Wright Giems stain method in cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis from solid tumors.

Zhenyu Pan, Guozi Yang, Yongxiang Wang, Hua He, Xiaochuan Pang, Yan Gao, Weiyan Shi, Yu Li, Lihua Dong, Yuanyuan Song

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03082144 (Involved-field Radiotherapy Combined With Concurrent Intrathecal-MTX Versus Intrathecal-Ara-C for Leptomeningeal Metastases From Solid Tumor), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03082144 phase2completednot on this mapstarted 2017, after this paper: background citation

Involved-field Radiotherapy Combined With Concurrent Intrathecal-MTX Versus Intrathecal-Ara-C for Leptomeningeal Metastases From Solid Tumor: A Randomized Phase II Clinical Trial

TypeinterventionalSponsorThe First Hospital of Jilin UniversityRan2017 to 2018Enrolled53ConditionsLeptomeningeal MetastasisArmsMTX, Ara-C, Radiotherapy
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Meningeal carcinomatosis: three case-reports.World journal of surgical oncology · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zhenyu PanDepartment of Radiation Oncology, the First Hospital, Jilin University, Changchun, China.
Guozi YangDepartment of Radiation Oncology, the First Hospital, Jilin University, Changchun, China.
Yongxiang WangDepartment of Clinical Laboratory, the First Hospital, Jilin University, Changchun, China.
Hua HeCancer Center, the First Hospital, Jilin University, Changchun, China.
Xiaochuan PangDepartment of Clinical Laboratory, the First Hospital, Jilin University, Changchun, China.
Yan GaoDepartment of Radiation Oncology, the First Hospital, Jilin University, Changchun, China.
Weiyan ShiDepartment of Radiation Oncology, the First Hospital, Jilin University, Changchun, China.
Yu LiDepartment of Radiation Oncology, the First Hospital, Jilin University, Changchun, China.
Lihua DongDepartment of Radiation Oncology, the First Hospital, Jilin University, Changchun, China.
Yuanyuan SongDepartment of Clinical Laboratory, the First Hospital, Jilin University, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present study was designed to determine whether the Thinprep plus Papanicolaou stain (Thinprep) method is more sensitive than the Cytospin-coupled Wright-Giemsa (WG) stain (Cytospin) method in diagnosis of leptomeningeal metastasis (LM) from malignant solid tumors in cerebrospinal fluid (CSF). We also explored if the Thinprep method could be used in the differential diagnosis of the type of primary tumor cells based on the morphology of tumor cells in CSF samples.

methodsThe morphological features of tumor cells in fresh CSF samples were analyzed using both methods. The tumor cell detection rates were compared between the two methods.

resultsUsing the Thinprep method, we found that each type of tumor cells in the CSF samples had specific identifiable morphological features linked to their primary cancer origins, such as adenocarcinomas originated from the lungs, breast, and stomach, and lung squamous cell carcinomas, small cell lung cancer, large-cell neuroendocrine lung cancer, hepatocellular carcinoma, and malignant melanoma. In a retrospective study with 88 LM patients, cancer cells were detected in 80 out of the 88 CSF samples. In the comparative study with 45 LM patients, the initial detection rate of the Thinprep method was significantly higher than that of the Cytospin method (73.3% vs. 57.8%, P<0.01). The cell morphology was better preserved and subcellular structures were clearer using the Thinprep method, compared to the Cytospin method.

conclusionsThe Thinprep method is more sensitive and suitable for LM diagnosis in CSF in patients with malignant solid tumors than the Cytospin method. The Thinprep method may facilitate primary tumor detection and help design early treatment regimens for LM patients with tumors of unknown primary origin.

Indexed as

AdultAgedAzure StainsFemaleHumansMaleMeningeal NeoplasmsMiddle AgedPapanicolaou TestProspective StudiesRetrospective StudiesSensitivity and SpecificityStaining and LabelingAzure Stains

Identifiers

PMID25850010
PMCPMC4388538
OpenAlexW2014616962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.